pharmaceuticalcommerce.com

CVS Caremark Restores Zepbound, Expands GLP-1 Access via Lilly App

CVS Health logoCVS Health
Sig3.22Sen+4.63Env0.00Soc+3.58Gov+1.28
Eli Lilly logoEli Lilly
Sig2.85Sen+2.60Env0.00Soc+1.05Gov+1.30

CVS Caremark reinstated Zepbound as a preferred formulary option and lifted its new-to-market block on Foundayo, citing ongoing GLP-1 pricing talks with manufacturers. With Lilly, CVS Health plans a Q4 2026 feature in its app to show transparent cash and reimbursed pricing for Zepbound and Foundayo and enable same-day pickup at about 9,000 retail stores.

Coverage (1)

ABOUT

What is Fimmer?

Most feeds treat all company headlines the same. An executive interview, an office closure, stock analysis, and a data breach can sit side by side with no sense of scale. Fimmer ranks coverage by what matters, so important events stand out and signals are prioritised over noise. We cluster related company news and score each story using a range of metrics, so you see the most crucial stories first.

SCORING

What do the scores mean?

Significance (0–10) measures the scale of the real-world impact. Sentiment and ESG (−10 to +10) indicate the tone of the coverage and whether the change relates to environmental, social, or governance factors. Together, these scores help distinguish meaningful developments from routine company news. More information about our scoring methodology can be found on our About page.

DISCOVERY

Explore more on Fimmer

Search more than 10,000 public companies, browse the company index, explore their scores, and read the coverage behind them, with our core features available to everyone for free.

For more advanced features, Pro gives you access to dynamic feeds, custom sorting, and more ways to track the companies that matter to you.

More with Pro